Africa: Pharma Pulls Back As Antimicrobial Resistance Threat Grows

Africa: Pharma Pulls Back As Antimicrobial Resistance Threat Grows

[Independent (Kampala)] The rising threat of antimicrobial resistance (AMR) continues to expose deep structural weaknesses in global pharmaceutical markets, with drug-resistant infections projected to claim nearly two million lives annually by 2050 unless investment and policy responses accelerate, according to the 2026 AMR Benchmark published by the Access to Medicine Foundation.

Pharma pulls back as antimicrobial resistance threat grows

Currently, drug-resistant infections are responsible for over one million direct deaths per year, with AMR contributing indirectly to more than four million additional fatalities annually NEWS ANALYSIS | PATRICIA AKANKWATSA | The rising threat of antimicrobial resistance (AMR) continues to expose deep structural weaknesses in global pharmaceutical markets, with drug-resistant infections projected to claim nearly two million lives annually by 205…